flu

04/08/2013 - 10:30

Scientists have described small genetic changes that enable the H5N1 bird flu virus to replicate more easily in the noses of mammals. So far there have only been isolated cases of bird flu in humans, and no widespread transmission as the H5N1 virus can’t replicate efficiently in the nose. The new study, using weakened viruses in the lab, supports the conclusions of controversial research published in 2012 which demonstrated that just a few genetic mutations could enable bird flu to spread between ferrets, which are used to model flu infection in humans.

 

02/13/2013 - 12:24

Outbreaks of disease in wildlife may seem remote and, for most humans, inconsequential. But disease events that arise in wild animal populations can be far-reaching and can even pose a threat to humans and domestic animals far removed from the source of animal affliction. New strains of flu, for example, often arise in birds and are first detected in surveys of waterfowl long before they begin to infect domestic animals and humans.

 

09/18/2012 - 10:48

Scientists from The Scripps Research Institute and Sea Lane Biotechnologies have solved the co-crystal structure of a human antibody that can neutralize influenza viruses in a unique way. The antibody recognizes the crucial structure that flu viruses use to attach to host cells, even though previously this structure had been thought too small for an antibody to grab effectively. The immune protein manages to hit this precise spot by using just a small part of its target-grabbing apparatus. In so doing, it can neutralize a broad range of dangerous flu viruses.

03/27/2012 - 11:16

The novel H1N1 flu pandemic in 2009 underscored weaknesses in methods widely used to diagnose the flu, from frequent false negatives to long wait times for results. Now a four-year, National Institutes of Health-funded study of 146 patients with flu-like symptoms spearheaded by Associate Professor Catherine Klapperich (BME, MSE) has validated a prototype rapid, low-cost, accurate, point-of-care device that promises a better standard of care.

02/27/2012 - 12:02

Princeton University-based researchers have found that the "universal" vaccine could for the first time allow for the effective, wide-scale prevention of flu by limiting the influenza virus' ability to spread and mutate. Universal, or cross-protective, vaccines — so named for their effectiveness against several flu strains — are being developed in various labs worldwide and some are already in clinical trials.

01/31/2012 - 09:36

Researchers at the University of Southampton, University of Oxford and Retroscreeen Virology Ltd have discovered a series of peptides, found on the internal structures of influenza viruses that could lead to the development of a universal vaccine for influenza, one that gives people immunity against all strains of the disease, including seasonal, avian, and swine flu.